‘Real World’ Comparison of First- and Second-Generation Antipsychotics in Regard to Length of Inpatient Hospitalization and Number of Re-hospitalizations-Reference-Cited by-同舟云学术

‘Real World’ Comparison of First- and Second-Generation Antipsychotics in Regard to Length of Inpatient Hospitalization and Number of Re-hospitalizations

Published:2007-12-01 Issue:1 Volume:79 Page:55-64
ISSN:0033-2720
Container-title:Psychiatric Quarterly
language:en
Short-container-title:Psychiatr Q

Author:

Advokat Claire,Hill Benjamin D.,Comaty Joseph E.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1007/s11126-007-9061-z.pdf

Reference34 articles.

1. Advokat C, Comaty JE: Pharmacoeconomics of the second-generation antipsychotics. Contemporary Psychiatry 3:1–10, 2004

2. Rosenheck RA, Leslie DL, Sindelar J, et al.: Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry 163:2080–2089, 2006

3. Gardner DM, Baldessarini RJ, Waraich P: Modern antipsychotic drugs: a critical review. Canadian Medical Association Journal 172:1703–1711, 2005

4. Leucht S, Wahlbeck K, Hamann J, et al.: New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis. Lancet 361:1581–1589, 2003

5. Rosenheck RA: Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator. Psychiatric Services 56:85–92, 2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competence to proceed in SVP commitment hearings: Irrelevant or fundamental due process right?;Behavioral Sciences & the Law;2010-09